Contact
Please use this form to send email to PR contact of this press release:
Kura Oncology Receives FDA Breakthrough Therapy Designation for Tipifarnib in Head and Neck Squamous Cell Carcinoma
TO:
Please use this form to send email to PR contact of this press release:
Kura Oncology Receives FDA Breakthrough Therapy Designation for Tipifarnib in Head and Neck Squamous Cell Carcinoma
TO: